Axel Pagenstecher Selected Research

Axel Pagenstecher Research Topics

Disease

14	Neoplasms (Cancer) 12/2021 - 07/2003
7	Inflammation (Inflammations) 01/2022 - 06/2002
5	Glioma (Gliomas) 08/2020 - 05/2006
5	Brain Neoplasms (Brain Tumor) 08/2020 - 06/2002
4	Glioblastoma (Glioblastoma Multiforme) 12/2021 - 10/2013
4	Infections 03/2008 - 12/2002
3	Epilepsy (Aura) 02/2020 - 10/2010
2	Central Nervous System Cavernous Hemangioma 01/2021 - 03/2009
2	Neoplasm Metastasis (Metastasis) 01/2018 - 06/2002
2	Carcinoma (Carcinomatosis) 03/2014 - 02/2009
2	Necrosis 10/2013 - 11/2010
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 08/2010 - 01/2002
1	Leukemia 11/2022
1	Hypersensitivity (Allergy) 11/2022
1	Parkinson Disease (Parkinson's Disease) 01/2022
1	Neuroinflammatory Diseases 01/2022
1	Insulinoma 01/2021
1	Partial Epilepsies (Epilepsy, Partial) 02/2020
1	Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis) 12/2018
1	Facies 12/2018
1	Muscle Hypotonia (Hypotonia) 12/2018
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 12/2018
1	Intellectual Disability (Idiocy) 12/2018
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Autoimmune Diseases of the Nervous System 12/2017
1	Abscess 03/2014
1	Multiple System Atrophy 07/2013
1	T-Cell Lymphoma (Lymphoma, T Cell) 05/2013
1	Encephalomyelitis (Myeloencephalitis) 01/2013
1	Astrocytoma (Pilocytic Astrocytoma) 01/2013
1	Vasculitis (Vasculitides) 11/2010
1	Nervous System Diseases (Neurological Disorders) 10/2010
1	Edema (Dropsy) 10/2010
1	Asthma (Bronchial Asthma) 08/2010
1	Respiratory Hypersensitivity 08/2010
1	Pathologic Neovascularization 03/2009
1	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 02/2009
1	Pituitary Neoplasms (Pituitary Adenoma) 02/2009
1	Multiple Endocrine Neoplasia Type 1 02/2009
1	Carcinogenesis 03/2008
1	Brain Diseases (Brain Disorder) 10/2006
1	Cerebral Malaria 09/2006
1	Persistent Infection 11/2005
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2005
1	Hydrocephalus (Hydrocephaly) 09/2004
1	Central Nervous System Diseases (CNS Diseases) 09/2004

Drug/Important Bio-Agent (IBA)

5	CytokinesIBA 01/2022 - 01/2002
4	Metalloproteases (Metalloproteinases)IBA 01/2021 - 05/2006
4	Interleukin-12 (IL 12)IBA 05/2009 - 01/2002
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2006
3	DisintegrinsIBA 01/2021 - 05/2006
2	AntigensIBA 01/2022 - 03/2008
2	Temozolomide (Temodar)FDA LinkGeneric 12/2021 - 06/2019
2	Carbonic Anhydrases (Carbonic Anhydrase)IBA 12/2021 - 06/2019
2	Matrix Metalloproteinases (MMPs)IBA 08/2020 - 09/2006
2	Pharmaceutical PreparationsIBA 02/2020 - 12/2017
2	AntibodiesIBA 01/2018 - 08/2010
2	Interferon-gamma (Interferon, gamma)IBA 05/2009 - 11/2005
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 03/2009 - 03/2009
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 09/2006 - 08/2002
1	ruxolitinibIBA 11/2022
1	Interleukin-7 (Interleukin 7)IBA 11/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	SynucleinsIBA 01/2022
1	IntegrinsIBA 10/2021
1	OsteopontinIBA 01/2021
1	von Willebrand FactorIBA 01/2021
1	Messenger RNA (mRNA)IBA 06/2019
1	LipofuscinIBA 12/2018
1	Phosphotransferases (Kinase)IBA 12/2018
1	Immune Checkpoint InhibitorsIBA 12/2017
1	NivolumabIBA 12/2017
1	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 03/2014
1	IronIBA 03/2014
1	Amyloid beta-PeptidesIBA 07/2013
1	AntioxidantsIBA 05/2013
1	DNA (Deoxyribonucleic Acid)IBA 05/2013
1	Interleukin-17 (Interleukin 17)IBA 01/2013
1	Antigen-Antibody Complex (Immune Complex)IBA 11/2010
1	HemosiderinIBA 10/2010
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 08/2010
1	TensinsIBA 03/2009
1	alpha Subunit Glycoprotein HormonesIBA 02/2009
1	ProlactinIBA 02/2009
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 02/2009
1	EphrinsIBA 03/2008
1	Antiviral Agents (Antivirals)IBA 03/2008
1	EphA2 ReceptorIBA 01/2008
1	Thalidomide (Thalomid)FDA Link 10/2006
1	Edetic Acid (EDTA)FDA Link 09/2006
1	Biological ProductsIBA 05/2006
1	Peptides (Polypeptides)IBA 05/2006
1	Peptide Hydrolases (Proteases)FDA Link 05/2006
1	Axonemal DyneinsIBA 09/2004
1	Viral AntigensIBA 09/2004

Therapy/Procedure

4	Radiotherapy 01/2013 - 06/2002
3	Drug Therapy (Chemotherapy) 12/2021 - 01/2013
2	Therapeutics 10/2013 - 05/2009
1	Immunotherapy 05/2009
1	Lymph Node Excision (Lymph Node Dissection) 08/2005